Morphine Market Size, Share and Segmentation by End User (Hospitals& Clinics, Ambulatory Surgical Centers), by Dosage Form (Injection, Oral), by Application (Pain Management, Diarrhea Suppressant, Cold &Cough Suppressant), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, and Global Forecast 2023-2030

Report Scope & Overview:

The Morphine Market Size was valued at USD 24.48 billion in 2022 and expected to reach USD 45.31 billion by 2030, and grow at a CAGR of 8% over the forecast period 2023-2030.

Morphine is an analgesic and narcotic medication derived from opium that is used to treat moderate to severe pain. According to the International Narcotics Control Board, 17 percent of the world's population consumes 92 percent of the world's morphine, while the rest of the world population consumes roughly 8 percent. The market for is being driven by reasons such as lifestyle changes that cause pain and an increase in the number of surgical operations as the drug is recommended for pain management post-surgery. However, the drug's addictive nature limits the global morphine market's expansion.

Because morphine is one of the most powerful pain medications, the increased use of morphine for pain treatment is a crucial factor contributing to market growth. Furthermore, the increasing rate of government legalisation of strong opioids for medicinal use in several emerging nations is likely to generate considerable potential for company expansion for existing players while facilitating easy entry for new players into the global morphine market.

MARKET DYNAMICS:

KEY DRIVERS:

• The global prevalence of orthopaedic diseases is increasing.

• Morphine demand is increasing as the cancer population grows.

RESTRAINTS:

• The addictive nature of the medicine limits the worldwide morphine market's expansion.

• Strict government regulations and morphine-related negative effects

IMPACT OF COVID-19:

Chronic pain management is difficult during the COVID-19 pandemic, owing to changes in the healthcare delivery system caused by safety concerns and social isolation. Chronic pain, on the other hand, is a big issue that affects 13.5 percent to 47 percent of the general population and can impose a significant financial burden. Furthermore, elective surgeries and consultations were cancelled; nearly 88 percent of cancer care centres faced challenges in providing standard cancer care due to a lack of personal protective equipment and a staff shortage, which impacted hospitals and pain clinics, ultimately affecting the morphine market.

More than 95 percent of morphine originates in Afghanistan, Mexico, and Myanmar, according to the supply chain. Opium poppy is produced in fields in all three countries, and harvesting opium is a labor-intensive job. However, the COVID-19 problem impedes opium production in various ways, including reduced worker availability, restricted trade due to rigorous border controls, and laboratories encountering chemical shortages due to lockdown measures. As a result, restricting cross-border imports and exports may cause supply chain disruptions, leading in considerable losses for morphine suppliers.

Injection Morphine is administered by injection into a vein, a muscle, or under the skin to patients who are vomiting, unconscious, or in an emergency.

Oral Due to the increasing prescription and capability of morphine as strong pain medications among pharmacists worldwide, the oral segment is predicted to rise rapidly in the global morphine market.

Management of Pain Morphine is a pain medication prescribed for moderate to severe pain. Extended-release morphine pills and capsules are only used to treat severe pain that has not been controlled by other pain medicines. Furthermore, opioids are critical in providing sufficient analgesia in acute post-operative conditions.

According to the International Osteoporosis Foundation, osteoporosis is one of the most serious public health crises affecting women, affecting more than 30% of the population in the United States and Europe each year and causing numerous fractures. According to research, the increasing prevalence of pain-related diseases drives sector growth. Cancer pain, neuropathic pain, osteoarthritis pain, and other pain management are sub-segments of the pain management segment.

Diarrhea Treatment Diarrhea is a common and potentially fatal complication in cancer patients. A local infection, systemic inflammation, or a side effect of radiotherapy or chemotherapy could all be to blame. Morphine works on mu-receptors in the colon, delaying transit time and increasing net absorption.

The European Society for Medical Oncology has demonstrated the role of opium-like morphine tincture (10 mg/mL morphine) in the treatment of diarrhoea (ESMO)

Cold and cough reliever Cough affects approximately 65 percent of lung cancer patients and 70 percent of COPD patients. Morphine sulphate is an effective antitussive in the treatment of persistent cough.

Clinics and hospitals The global expansion of hospital infrastructure is propelling the morphine market. Morphine demand in hospitals and clinics increases as the number of orthopaedic problems and cancer patients increases. Hospitals and clinics held the majority share in 2021 because to the significant number of orthopaedic surgeries and cancer therapy performed in hospitals and clinics as the incidence of cancer and orthopaedic problems increased.

In the United Kingdom, more than 10 million people suffer from arthritis or other joint-related ailments. Ambulatory Surgical Facilities: Outpatient services can include a variety of procedures such as surgeries, minimally invasive therapies, and others. Furthermore, ambulatory surgery centres are designed to maximise the efficiency of health care delivery, propelling the morphine market sector forward.

Pharmacies in Hospitals In 2021, the hospital pharmacy segment retained a sizable market share. Because most hospitals have in-house pharmacies, the need for a prescription for chemotherapy-related pain and other types of chronic pain in orthopaedic conditions such as arthritis, fibromyalgia, osteoporosis, and elbow discomfort strengthens the hospital pharmacy business.

Online Shops Because online stores are easy, time-saving, and cost-effective, they are predicted to be the fastest-growing segment during the forecast period.

Pharmacy Chains A retail pharmacy is an independent pharmacy, a supermarket pharmacy, a chain pharmacy, or a mass merchandiser pharmacy that has a state licence to distribute pharmaceuticals to the general public at retail prices. The expansion of the retail pharmacies category can be attributed to the ease of access to these distribution channels, particularly in rural areas and tier-II cities in developing and underdeveloped economies.

VALUE CHAIN ANALYSIS:

The global morphine market is expanding gradually and is likely to continue doing so in the near future. This is attributable to an increase in the use of morphine for pain management, improved morphine regulations, established healthcare infrastructure, and the availability of better medical facilities, as well as an increase in the patient pool with cancer, orthopaedic disorders, and other chronic diseases. The global morphine market value chain study includes five important components: raw material procurement, R&D, product manufacturing, distribution and sales, and post-sales monitoring.

MARKET PLAYER

Mallinckrodt Pharmaceuticals, Sanofi Winthrop Industrie, Macfarlan Smith, Northeast Pharmaceutical Group, Pfizer Inc., Verve Health Care Ltd., Alcaliber, Purdue Pharma, Sun Pharmaceutical Industries, Qinghai Pharmaceutical.

MARKET SEGMENTS:

by End User

• Hospitals& Clinics

• Ambulatory Surgical Centers

by Dosage Form

• Injection

• Oral

by Application

• Pain Management

• Diarrhea Suppressant

• Cold &Cough Suppressant

by Distribution Channel

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

REGIONAL ANALYSIS:

The Asia-Pacific morphine market is expected to be the fastest expanding in the region. The increased frequency of chronic diseases such as cardiovascular problems, as well as an increasing patient population and innovative treatment options, are the primary drivers of market expansion. Furthermore, increased healthcare expenditure in the region is propelling the Asia Pacific morphine market forward.

The morphine market is highly consolidated, with a number of major players engaged in this field. They primarily do research and development for pain management and other therapeutic applications such as cough and diarrhoea suppression in a variety of clinical and research settings.

Furthermore, market participants are offering mergers and acquisitions, contractual agreements, new product launches, increased investments, and collaboration with other companies in order to grow their global presence.

REGIONAL COVERAGE:

• North America

  • USA

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • The Netherlands

  • Rest of Europe

• Asia-Pacific

  • Japan

  • south Korea

  • China

  • India

  • Australia

  • Rest of Asia-Pacific

• The Middle East & Africa

  • Israel

  • UAE

  • South Africa

  • Rest of Middle East & Africa

• Latin America

  • Brazil

  • Argentina

  • Rest of Latin America

Frequently Asked Questions (FAQ) :